Russian industry struggling with new government rules

31 January 2020

In 2020, the national regime regarding the procurement of goods, work, services does not apply to products from the EAEU countries (Belarus, Kazakhstan, Armenia, Kyrgyzstan), states a press release from the Association of Russian Pharmaceutical Manufacturers (ARPM).

Products from these states are not equivalent to foreign products under the national regime. These measures are designed to simplify and maintain the share of EAEU goods at the level of 50%. The government prepared the relevant amendments in 44-FL “On the contract system”.

National regime includes preferences, restrictions and prohibitions. So, according to the new rules, it is forbidden to purchase foreign products for the defense and security of the country, but otherwise the “Third Extra” mechanism and price preferences will be applied.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK